GLP-1 drugs first made their mark in diabetes and obesity, but many research efforts are underway to bring such therapies to more indications. Altimmune now has mid-stage clinical trial results …
Health
-
-
Health
Included Health to Acquire Firefly Health to Expand Alternative Health Plan Offering for Employers
Included Health, a navigation and virtual care company, announced Tuesday that it plans to acquire Firefly Health, a primary care and health plan provider. San Francisco-based Included Health provides virtual …
-
More than six in ten Americans had some sort of symptom signaling poor digestive health in just the past week, yet most still have no way to track what’s happening …
-
It’s the latest industry recommendation: that health plans move routine Utilization Management (UM) in-house and leave complex, specialty care to the experts. As both a nurse and a clinical operations …
-
For decades, Alzheimer’s disease has been detected far too late. By the time memory and thinking problems disrupt daily life, underlying biological changes have often been progressing quietly for years. …
-
Argenx established itself in immunology with a single drug offering potential use across a range of rare inflammatory disorders. The biotech is now expanding to more prevalent conditions through a …
-
Value-based care has become one of the most misunderstood terms in the healthcare industry, according to Lakshmi Halasyamani, chief clinical officer at Endeavor Health. She said hospitals tend to treat …
-
Prior authorization has become one of healthcare’s most expensive administrative bottlenecks, affecting far more than physician practices. Across hospitals and health systems, it slows patient access, adds labor-intensive work, increases …
-
Healh insurers are interested in assessing the potential for AI to improve everything from prior authorization to member management. But data fragmentation poses an enormous challenge to AI readiness in …
-
Across the country, community and mid-size hospitals are facing a new financial reality: a shift to a riskier payer mix. Commercial coverage that once cross-subsidized care is shrinking, Medicare is …